Management of toxicities of immune checkpoint inhibitors

Title
Management of toxicities of immune checkpoint inhibitors
Authors
Keywords
Immune-checkpoint inhibitors, Immune-related adverse events, Ipilimumab, Nivolumab, Pembrolizumab, Melanoma, Lung cancer, Renal cancer
Journal
CANCER TREATMENT REVIEWS
Volume 44, Issue -, Pages 51-60
Publisher
Elsevier BV
Online
2016-02-07
DOI
10.1016/j.ctrv.2016.02.001

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started